HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cocrystal Pharma (NASDAQ:COCP) with a Buy and lowers the price target from $42 to $35.
Wells Fargo Maintains Overweight on Atmos Energy, Lowers Price Target to $120
Wells Fargo analyst Sarah Akers maintains Atmos Energy (NYSE:ATO) with a Overweight and lowers the price target from $130 to $120.